Equities

Agronomics Ltd

ANIC:LSE

Agronomics Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)6.30
  • Today's Change0.00 / 0.00%
  • Shares traded1.25m
  • 1 Year change43.18%
  • Beta2.0795
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Agronomics Ltd's revenues fell 200.91% from -8.34m to -25.10m. a loss of 10.99m to a larger loss of 32.75m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-23.22%
Return on equity-23.24%
Return on investment-23.23%
More ▼

Cash flow in GBPView more

In 2025, Agronomics Ltd increased its cash reserves by 15.32%, or 479.09k. Cash Flow from Investing totalled 9.11m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 8.63m for operations while cash generated from financing totalled 1.71k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.1234
Tangible book value per share0.1234
More ▼

Balance sheet in GBPView more

Agronomics Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio--
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items dropped -195.18%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-196.80
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.